Sculptor Capital LP Intercept Pharmaceuticals, Inc. Put Options Transaction History

Sculptor Capital LP

  • $3.13 Billion
  • Q1 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 13, 2022
SELL
$13.37 - $17.79 $1.91 Million - $2.54 Million
-142,700 Reduced 78.11%
40,000 $651,000
Q3 2017

Nov 13, 2017
BUY
$57.01 - $118.75 $10.4 Million - $21.7 Million
182,700
182,700 $0

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email